# A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

> clinical trial · VERIFIED · 2026-07-29

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Hepatocellular Carcinoma

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04712643

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.